Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial.
Pneumonia is a common and potentially serious infection that affects children throughout the world. The aim of this study was to compare between cefuroxim and cefotaxim in the treatment of children with pneumonia. All 3 months-5 years old children admitted from 2/1/2012 to 4/31/2012 at Dorrah Hospit...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Turaz Bilim
2014-09-01
|
| Series: | Medicine Science |
| Subjects: | |
| Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=154012 |
| _version_ | 1797328492471255040 |
|---|---|
| author | Hashem Mohammed Mansour Shaban Al Mobayed Ahmed El Manasra Rola S. Abudalfa |
| author_facet | Hashem Mohammed Mansour Shaban Al Mobayed Ahmed El Manasra Rola S. Abudalfa |
| author_sort | Hashem Mohammed Mansour |
| collection | DOAJ |
| description | Pneumonia is a common and potentially serious infection that affects children throughout the world. The aim of this study was to compare between cefuroxim and cefotaxim in the treatment of children with pneumonia. All 3 months-5 years old children admitted from 2/1/2012 to 4/31/2012 at Dorrah Hospital in Gaza were included in this study. The clinical outcome, length of hospital stay, and the association of pneumonia incidence to gender and age were compared. Of the 110 children admitted for non-complicated community acquired pneumonia (CAP), sixty patients were treated with cefuroxime and fifty were treated with cefotaxim. Clinical outcome and length of hospital stay is similar between both groups. Interestingly, the pneumonia incidence is higher in younger children and males. In conclusion, both drugs have similar treatment efficacy in terms of clinical outcome and the length of hospital stay. However, cefuroxim has several advantages over cefotaxim, including (1) oral form, allowing outpatient management, (2) less frequency of administration. Thereby, it should be recommended to treat pneumonia in children. [Med-Science 2014; 3(3.000): 1470-8] |
| first_indexed | 2024-03-08T06:52:35Z |
| format | Article |
| id | doaj.art-fa5b40a0086c416cbe63ecdaa3a808c2 |
| institution | Directory Open Access Journal |
| issn | 2147-0634 |
| language | English |
| last_indexed | 2024-03-08T06:52:35Z |
| publishDate | 2014-09-01 |
| publisher | Society of Turaz Bilim |
| record_format | Article |
| series | Medicine Science |
| spelling | doaj.art-fa5b40a0086c416cbe63ecdaa3a808c22024-02-03T06:40:33ZengSociety of Turaz BilimMedicine Science2147-06342014-09-01331470810.5455/medscience.2014.03.8149154012Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial.Hashem Mohammed Mansour0Shaban Al MobayedAhmed El ManasraRola S. AbudalfaHead of the Scientific Committe in Kamal Odwan HospitalPneumonia is a common and potentially serious infection that affects children throughout the world. The aim of this study was to compare between cefuroxim and cefotaxim in the treatment of children with pneumonia. All 3 months-5 years old children admitted from 2/1/2012 to 4/31/2012 at Dorrah Hospital in Gaza were included in this study. The clinical outcome, length of hospital stay, and the association of pneumonia incidence to gender and age were compared. Of the 110 children admitted for non-complicated community acquired pneumonia (CAP), sixty patients were treated with cefuroxime and fifty were treated with cefotaxim. Clinical outcome and length of hospital stay is similar between both groups. Interestingly, the pneumonia incidence is higher in younger children and males. In conclusion, both drugs have similar treatment efficacy in terms of clinical outcome and the length of hospital stay. However, cefuroxim has several advantages over cefotaxim, including (1) oral form, allowing outpatient management, (2) less frequency of administration. Thereby, it should be recommended to treat pneumonia in children. [Med-Science 2014; 3(3.000): 1470-8]http://www.ejmanager.com/fulltextpdf.php?mno=154012Cefuroximecefotaximpneumoniabacteriaampicillin |
| spellingShingle | Hashem Mohammed Mansour Shaban Al Mobayed Ahmed El Manasra Rola S. Abudalfa Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial. Medicine Science Cefuroxime cefotaxim pneumonia bacteria ampicillin |
| title | Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial. |
| title_full | Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial. |
| title_fullStr | Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial. |
| title_full_unstemmed | Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial. |
| title_short | Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial. |
| title_sort | comparison of cefuroxim versus cefotaxim in the treatment of pneumonia in children aged 3 months 5 years an imaging and clinical examination evidence randomized controlled trial |
| topic | Cefuroxime cefotaxim pneumonia bacteria ampicillin |
| url | http://www.ejmanager.com/fulltextpdf.php?mno=154012 |
| work_keys_str_mv | AT hashemmohammedmansour comparisonofcefuroximversuscefotaximinthetreatmentofpneumoniainchildrenaged3months5yearsanimagingandclinicalexaminationevidencerandomizedcontrolledtrial AT shabanalmobayed comparisonofcefuroximversuscefotaximinthetreatmentofpneumoniainchildrenaged3months5yearsanimagingandclinicalexaminationevidencerandomizedcontrolledtrial AT ahmedelmanasra comparisonofcefuroximversuscefotaximinthetreatmentofpneumoniainchildrenaged3months5yearsanimagingandclinicalexaminationevidencerandomizedcontrolledtrial AT rolasabudalfa comparisonofcefuroximversuscefotaximinthetreatmentofpneumoniainchildrenaged3months5yearsanimagingandclinicalexaminationevidencerandomizedcontrolledtrial |